Cancers, Vol. 16, Pages 1282: Temporal Trends in Treatment and Outcomes of Endometrial Carcinoma in the United States, 2005 & ndash;2020

Cancers, Vol. 16, Pages 1282: Temporal Trends in Treatment and Outcomes of Endometrial Carcinoma in the United States, 2005–2020 Cancers doi: 10.3390/cancers16071282 Authors: Victor Adekanmbi Fangjian Guo Christine D. Hsu Daoqi Gao Efstathia Polychronopoulou Itunu Sokale Yong-Fang Kuo Abbey B. Berenson Endometrial cancer has continued to see a rising incidence in the US over the years. The main aim of this study was to assess current trends in patients’ characteristics and outcomes of treatment for endometrial carcinoma over 16 years. A dataset from the National Cancer Database (NCDB) for patients diagnosed with endometrial carcinoma from 2005 to 2020 was used in this retrospective, case series study. The main outcomes and measures of interest included tumor characteristics, hospitalization, treatments, mortality, and overall survival. Then, 569,817 patients who were diagnosed with endometrial carcinoma were included in this study. The mean (SD) age at diagnosis was 62.7 (11.6) years, but 66,184 patients (11.6%) were younger than 50 years, indicating that more patients are getting diagnosed at younger ages. Of the patients studied, 37,079 (6.3%) were Hispanic, 52,801 (9.3%) were non-Hispanic Black, 432,058 (75.8%) were non-Hispanic White, and 48,879 (8.6%) were other non-Hispanic. Patients in the 4th period from 2017 to 2020 were diagnosed more with stage IV (7.1% vs. 5.2% vs. 5.4% vs. 5.9%; p < 0.001) disease compared ...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research